DFDA

Cognitive Behavioral Therapy (CBT)

Treatment for Amphetamine Use Disorders

Typical Dosage: 1-2 sessions per week (60-90 minutes)

Effectiveness
75%
Safety Score
95%
Clinical Trials
2
Participants
3.2K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
95
DangerousModerateSafe
Treatment Details
Dosage Range
1-2 sessions per week (60-90 minutes)
Time to Effect
4-8 weeks
Treatment Duration
12-20 weeks
Evidence Quality
HIGH
Number Needed to Treat (NNT)
7(Treat 7 patients to see 1 additional successful outcome)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$400
Side Effect Mgmt:$0
Total Annual:$400
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
ICER
$50,000/QALY
QALYs Gained
0.15
Outcome-Based Costs
Cost per Responder
$6,000
Cost per Remission
$12,000
Cognitive Behavioral Therapy (CBT) Outcomes

for Amphetamine Use Disorders

Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+50%
Remission Rate
+25%
Common Side Effects
Emotional discomfort during sessions
+10%
Temporary increase in anxiety or depression
+3%

Sources:

nih.gov
campbellcollaboration.org
researchgate.net

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
1 completed trial for Cognitive Behavioral Therapy (CBT) in Amphetamine Use Disorders

Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.

NCT02634684COMPLETEDPHASE2
View Study
82 participants
INTERVENTIONAL
San Diego, United States
Started: Jul 1, 2014